SCHEMBL5374527

SCHEMBL5374527

Nc1ccc(C(=O)O)c(CCl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
KDM4E B2RXH2 6/20 0.55
MAPT P10636 5/20 0.55
CYP3A4 P08684 4/20 0.55
GAA P10253 2/20 0.55
ESR2 Q92731 1/20 0.55
PTPN1 P18031 1/20 0.55
TDP1 Q9NUW8 4/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
THRB P10828 2/20 0.50
RECQL P46063 2/20 0.50
POLB P06746 2/20 0.50
CASP1 P29466 2/20 0.50
MCL1 Q07820 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KDR P35968 2/20 0.50
USP2 O75604 1/20 0.50
PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3955858 0.98 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL27596046 0.85 KDM4E (0.55) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL367880 0.84 KDM4E (0.59) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL28062236 0.84 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTCYP3A4GAA
Hydrochloric Acid SCHEMBL27596045 0.83 TDP1 (0.58) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL182142 0.82 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL8768830 0.82 KDM4E (0.57) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL29632107 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL343331 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL29632227 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTCYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101563347-A Vasopressin V1a antagonists VANTIA LTD (GB) 2009-10-21 CN disclosed
CN-101379044-A Heterobicyclic sulfonamide derivatives for the treatment of diabetes HOFFMANN LA ROCHE (CH) 2009-03-04 CN disclosed
CN-100349896-C Benzamide derivatives as oxytocin agonists and vasopressin antagonists FERRING BV (NL) 2007-11-21 CN disclosed
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
CN-1751050-A Benzamide derivatives as oxytocin agonists and vasopressin antagonists FERRING BV (NL) 2006-03-22 CN disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
CN-1668613-A Flavone derivatives as cyclin dependent kinase inhibitors NICHOLAS PIRAMAL INDIA LTD (IN) 2005-09-14 CN disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
US-6340685-B1 ANTIINFLAMMATORY AGENTS SCIOS, INC. 2002-01-22 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed